Current literature continues to help the protection of dual therapy as opposed to monotherapy. In 2017, the FDA approved the safety of twin therapy in asthmatic people whilst warning towards the use of monotherapy of LABAs. The worldwide Initiative for COPD and Nationwide Bronchial asthma Instructio